These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2551661)

  • 1. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
    Bagdy G; Calogero AE; Murphy DL; Szemeredi K
    Endocrinology; 1989 Nov; 125(5):2664-9. PubMed ID: 2551661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of hypothalamic serotonin in activation of the sympathoadrenomedullary system and hypothalamo-pituitary-adrenocortical axis in male Wistar rats.
    Korte SM; Van Duin S; Bouws GA; Koolhaas JM; Bohus B
    Eur J Pharmacol; 1991 May; 197(2-3):225-8. PubMed ID: 1833209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
    Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
    Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
    Bagdy G; Calogero AE; Szemeredi K; Gomez MT; Murphy DL; Chrousos GP; Gold PW
    Brain Res; 1990 Dec; 537(1-2):227-32. PubMed ID: 2150776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central stimulation of adrenocortical secretion by 5-hydroxytryptamine1A agonists is mediated by sympathomedullary activation.
    Saphier D; Welch JE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):905-17. PubMed ID: 7932203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-chlorophenylalanine attenuates the pituitary-adrenocortical response to 5-HT1A receptor agonists in mice.
    Matsuda T; Kanda T; Seong YH; Baba A; Iwata H
    Eur J Pharmacol; 1990 Jun; 181(3):295-7. PubMed ID: 1696545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ; Edwards E; Nemeroff CB
    Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: evidence for the roles of stressor duration and serotonin.
    Cassano WJ; D'mello AP
    Neuroendocrinology; 2001 Sep; 74(3):167-77. PubMed ID: 11528218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
    Calogero AE; Bagdy G; Moncada ML; D'Agata R
    J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
    Chaouloff F; Baudrie V; Layeillon C; Broqua P
    Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE; Farrar GE; Dunn AJ; Saphier D
    Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 5-HT
    Stamper CE; Hassell JE; Kapitz AJ; Renner KJ; Orchinik M; Lowry CA
    Stress; 2017 Mar; 20(2):223-230. PubMed ID: 28345385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors.
    Mikkelsen JD; Hay-Schmidt A; Kiss A
    Ann N Y Acad Sci; 2004 Jun; 1018():65-70. PubMed ID: 15240353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of endogeneous glutamate in the stimulatory effect of norepinephrine and serotonin on the hypothalamo-pituitary-adrenocortical axis.
    Feldman S; Weidenfeld J
    Neuroendocrinology; 2004 Jan; 79(1):43-53. PubMed ID: 14755133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    Welch JE; Saphier D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.